Advertise Your Biotechnology, Pharmaceutical, Healthcare, or Medical Company To Investors

Life Science Investors Start Here

Amplify your company's brand and news by partnering with the largest platform dedicated to connecting investors with emerging life science stocks.

Life Sciences CEOs, IR Reps, and Digital Agencies Take Notice

Health Stocks Hub (HSH) is 100% dedicated to publicly traded biotech, pharma, medical, and health technology stocks. We reach the web's largest and most targeted niche of investors specifically focused on identifying new investment opportunities within the life sciences sector and its associated industries. Our flexible campaigns allow companies to rapidly launch broad market awareness programs as well as deploy targeted investor outreach strategies across a variety of mediums and outlets:

Daily Newsletter

Disseminate your news through our flagship daily morning newsletter and reach institutional investors, private equity firms, analysts and retail investors.

Platform Promotion

Build broad market awareness and relay your value proposition to our highly targeted audience across the feature rich HSH platform.

Investor Network

Start growing your distribution network or leverage our existing audience through enhanced analytics, remarketing campaigns, lead generation and more.

Put your news in front of investors, private equity firms, and analysts

Our flagship daily newsletter is the only of its kind and includes daily compilation and distribution. This double opt-in subscriber newsletter is distributed Monday-Friday to institutional and retail investors, brokers, analysts and more.

Health Stocks Brief for

Today's Top Headlines

Today's Top Health Stock News

Surmodics Announces Successful First Patient Use of Sublime™ Radial Access Microcatheter Designed for the Periphery

Sublime Radial Access Platform to include the industry’s first suite of torqueable peripheral microcatheters, designed for navigating tortuosity and crossing complex lesions and available for both transradial and transfemoral procedures... Read More

AbbVie Receives Positive CHMP Opinion for Mirvetuximab Soravtansine (ELAHERE®) for the Treatment of Certain Adult Ovarian Cancer

Merck Receives Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab) Regimens as Treatment for Patients With Two Types of Gynecologic Cancers...

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union

Stryker completes acquisition of NICO Corporation, expanding minimally invasive solutions for brain tumor removal and stroke care

Regeneron Pharmaceuticals: Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children...

Samsung Bioepis and Biogen Receive Positive CHMP Opinion for Aflibercept Biosimilar, OPUVIZ™

Cardinal Health to acquire Integrated Oncology Network, a physician-led independent community oncology network

Apellis Pharmaceuticals Receives Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU Following Re-Examination

NervGen Pharma to Present at the Unite 2 Fight Paralysis 19th Annual Science & Advocacy Symposium Focused on Spinal Cord Injury

Alpha Tau Medical Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised...

Promote your company to investors across the entire platform

Gain full exposure across the entire Health Stocks Hub platform through featured placement, branded news and stock quotes, banner rotation, featured profiles, video capsules, and much more.